LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Reset all filters
01 1LGM Pharma
02 1Shanghai Minbiotech
03 1Sichuan Qingmu Pharmaceutical
04 1Alembic Pharmaceuticals Limited
05 1Alfa Chemistry
06 1Anax Laboratories
07 1Aspen Bio
08 1Beijing Sjar Technology Development
09 1Biotechnica DWC
10 1Cipla
11 1DEAFARMA
12 1Guangdong Raffles PharmaTech Co Ltd
13 1Guangzhou Tosun Pharmaceutical
14 1Hangzhou Longshine Bio-Tech
15 1Hetero Drugs
16 1Hunan Huateng Pharmaceutical Co ltd
17 1Lunan Pharmaceutical
18 2MSN Laboratories
19 1Mac-Chem Products (India) Pvt.Ltd
20 1Morepen Laboratories
21 2Pfizer Inc
22 1Sakar Healthcare
23 1Shenzhen HwaGen Pharmaceutical
24 1Shilpa Medicare
25 1Synthon Pharmaceuticals
26 1Wisdom Pharmaceutical
27 1Zhejiang Jiuzhou Pharmaceutical
Reset all filters
01 1Algeria
02 11China
03 11India
04 1Italy
05 1Netherlands
06 4U.S.A
Reset all filters
01 7Active
02 22Blank
01 29Blank
Reset all filters
01 29Blank
Reset all filters
01 1WC-0041
02 1WC-0082
03 1WC-0147
04 1WC-0349
05 25Blank
Reset all filters
01 1Su189-15-ND
02 1Su87-23-ND
03 27Blank
Reset all filters
01 154893-0032
02 154893-0043
03 182920-028
04 26Blank
01 29Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-06-27
Pay. Date : 2023-02-06
DMF Number : 37971
Submission : 2023-02-02
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39323
Submission : 2023-12-27
Status : Active
Type : II


GDUFA
DMF Review : Reviewed
Rev. Date : 2016-04-15
Pay. Date : 2015-10-29
DMF Number : 29918
Submission : 2015-10-10
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2016-02-05
Pay. Date : 2015-12-23
DMF Number : 30104
Submission : 2015-12-24
Status : Active
Type : II
Date of Issue : 2026-01-01
Valid Till : 2028-07-02
Written Confirmation Number : WC-0147
Address of the Firm :
NDC Package Code : 82920-028
Start Marketing Date : 2022-08-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT



17
PharmaCompass offers a list of Axitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Axitinib manufacturer or Axitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Axitinib manufacturer or Axitinib supplier.
A Axitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Axitinib, including repackagers and relabelers. The FDA regulates Axitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Axitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Axitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Axitinib supplier is an individual or a company that provides Axitinib active pharmaceutical ingredient (API) or Axitinib finished formulations upon request. The Axitinib suppliers may include Axitinib API manufacturers, exporters, distributors and traders.
click here to find a list of Axitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
We have 27 companies offering Axitinib
Get in contact with the supplier of your choice: